Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology
暂无分享,去创建一个
J. Almeida | L. Quintans-Júnior | R. Almeida | L. C. Morais | C. I. Franco | L. C. S. L. Morais | L. J. Quintans-Júnior | C. I. F. Franco | J. R. G. S. Almeida | R. N. Almeida | J. Almeida | L. C. S. Morais | L.C.S.L. Morais | C. Franco | L. Morais | Jackson Roberto Guedes da Silva Almeida | Lucindo J. Quintans-Júnior | Reinaldo Nóbrega de Almeida
[1] A. Cáceres,et al. Neuropharmacological profile of ethnomedicinal plants of Guatemala. , 2001, Journal of ethnopharmacology.
[2] P. Riederer,et al. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man , 2005, Journal of Neural Transmission.
[3] R. Young. Update on Parkinson's disease. , 1999, American family physician.
[4] M. Fonteles,et al. Screening for anticancer activity of plants from the Northeast of Brazil , 1997 .
[5] B. Manyam,et al. Mucuna pruriens proves more effective than L‐DOPA in Parkinson's disease animal model , 1997 .
[6] R. Elble. Central mechanisms of tremor. , 1996, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[7] I. Raskin,et al. Plants and human health in the twenty-first century. , 2002, Trends in biotechnology.
[8] K. Fukuzaki,et al. Effects of Ropinirole on Various Parkinsonian Models in Mice, Rats, and Cynomolgus Monkeys , 2000, Pharmacology Biochemistry and Behavior.
[9] R. Pérez,et al. Neuropharmacological activity of Solanum nigrum fruit. , 1998, Journal of ethnopharmacology.
[10] Coward Dm,et al. The pharmacology of N-carbamoyl-2-(2,6-dichlorophenyl)acetamidine hydrochloride (LON-954) a new tremorogenic agent. , 1977 .
[11] W. Cui,et al. Pharmacology: Anti‐nicotinic Properties of Anticholinergic Antiparkinson Drugs , 1998 .
[12] David J Newman,et al. Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.
[13] R. Llinás,et al. Properties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurones in vitro. , 1981, The Journal of physiology.
[14] Guanghui Wang,et al. Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine , 2001, Psychopharmacology.
[15] P. Slater,et al. Effects of naltrexone and prolyl-leucyl-glycinamide on drug-induced tremor and rigidity in the rat , 1981, Neuropharmacology.
[16] T. Klockgether,et al. Effects of the antiparkinsonian drug budipine on central neurotransmitter systems. , 1996, European journal of pharmacology.
[17] S. M. Rates,et al. Plants as source of drugs. , 2001, Toxicon : official journal of the International Society on Toxinology.
[18] P. Slater,et al. Effect of lesioning dopamine, noradrenaline and 5-hydroxytryptamine pathways on tremorine-induced tremor and rigidity , 1982, Neuropharmacology.
[19] H. Shinozaki,et al. Modification of drug-induced tremor by systemic administration of kainic acid and quisqualic acid in mice , 1987, Neuropharmacology.
[20] R. Bye,et al. Antimicrobial and cytotoxic activities of some crude drug extracts from Mexican medicinal plants. , 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[21] P. K. Mohan,et al. Association of l-DOPA with recovery following Ayurveda medication in Parkinson’s disease , 2000, Journal of the Neurological Sciences.
[22] R. Llinás,et al. Oscillatory properties of guinea‐pig inferior olivary neurones and their pharmacological modulation: an in vitro study. , 1986, The Journal of physiology.
[23] J. Harindran.,et al. Pimprinine, an extracellular alkaloid produced by Streptomyces CDRIL-312: fermentation, isolation and pharmacological activity. , 2001, Journal of biotechnology.
[24] V. Sethy,et al. Pharmacokinetics of muscarinic cholinergic drugs as determined by ex vivo (3H)-oxotremorine-M binding. , 1990, Journal of pharmacological methods.
[25] J. Salamone,et al. Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. , 1997, European journal of pharmacology.
[26] M. Palkovits,et al. Regional distribution of muscarinic cholinergic receptors in rat brain , 1978, Brain Research.
[27] J. Bhattacharyya,et al. Epi-isoshinanolone from Plumbago scandens , 1986 .
[28] J. Harborne. Comparative biochemistry of the flavonoids-IV. Correlations between chemistry, pollen morphology and systematics in the family Plumbaginaceae. , 1967 .
[29] D. Brocks. Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective. , 1999, Journal of Pharmacy & Pharmaceutical Sciences.
[30] P. Slater,et al. Effects of lesioning basal ganglia nuclei and output pathways on tremorine-induced tremor in rats , 1982, Journal of the Neurological Sciences.
[31] J. Carr. Tremor in Parkinson's disease. , 2002, Parkinsonism & related disorders.